1: Arlinghaus RB. Related Articles, Links
Bcr: a negative regulator of the Bcr-Abl oncoprotein in leukemia.
Oncogene. 2002 Dec 9;21(56):8560-7.
PMID: 12476302 [PubMed - in process]
2: Herold R, Stibenz D, Hartmann R, Henze G, Buhrer C. Related Articles, Links
Soluble l-selectin (sCD62L) in relapsed childhood acute lymphoblastic leukaemia.
Br J Haematol. 2002 Dec;119(3):677-84.
PMID: 12437644 [PubMed - in process]
3: Bohmer FD, Karagyozov L, Uecker A, Serve H, Botzki A, Mahboobi S, Dove S. Related Articles, Links
A single amino acid exchange inverts susceptibility of related receptor tyrosine kinases for the ATP-site inhibitor STI-571.
J Biol Chem. 2002 Nov 14 [epub ahead of print]
PMID: 12435730 [PubMed - as supplied by publisher]
4: Khac FN, Waill MC, Romana SP, Radford-Weiss I, Busson M, Collonge-Rame MA, Ribadeau-Dumas A, Piffaut MC, Daniel MT, Davi F, Merle-Beral H, Berger R, Arock M. Related Articles, Links
Identical abnormality of the short arm of chromosome 18 in two Philadelphia-positive chronic myelocytic leukemia patients with erythroblastic transformation, resulting in duplication of BCR-ABL1 fusion.
Cancer Genet Cytogenet. 2002 Oct 1;138(1):22-6.
PMID: 12419580 [PubMed - indexed for MEDLINE]
5: Ricci C, Scappini B, Divoky V, Gatto S, Onida F, Verstovsek S, Kantarjian HM, Beran M. Related Articles, Links
Mutation in the ATP-binding pocket of the ABL kinase domain in an STI571-resistant BCR/ABL-positive cell line.
Cancer Res. 2002 Nov 1;62(21):5995-8.
PMID: 12414617 [PubMed - indexed for MEDLINE]
Time used: 47 miliseconds.

Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005